Presynaptic regulation of dopaminergic neurotransmission

Journal of Neurochemistry

Volumn 87, Issue 2, 2003, Pages 273-289

  Schmitz, Yvonne ^c   Benoit Marand, Marianne ^a   Gonon, François ^a   Sulzer, David ^b  

^a CNRS   (France)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

Amphetamine; Cocaine; D2 receptor; Dopamine; Dopamine transporter; Release; Uptake

Indexed keywords

AMPHETAMINE; CARBON FIBER; CATECHOLAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT;

BRAIN TISSUE; CATECHOLAMINE RELEASE; CATECHOLAMINE UPTAKE; DIFFUSION; DOPAMINERGIC TRANSMISSION; ELECTROCHEMISTRY; ELECTRODE; HUMAN; NERVE CELL CULTURE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; ELECTROPHYSIOLOGY; HUMANS; MICROELECTRODES; NEURONS; PRESYNAPTIC TERMINALS; SYNAPTIC TRANSMISSION;

EID: 0141987926     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02050.x     Document Type: Review

References (264)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W. H., Castillo P. E., Shinsky N., Verdugo J. M., Armanini M., Ryan A. et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
2. Ackerman J. M. and White F. J. (1990) A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117, 181-187.
3. Araujo D. M., Hilt D. C., Miller P. J., Wen D., Jiao S. and Lapchak P. A. (1997) ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways. Neuroscience 80, 9-16.
4. Aretha C. W., Sinha A. and Galloway M. P. (1995) Dopamine D3-preferring ligands act at synthesis modulating autoreceptors. J. Pharmacol. Exp. Ther. 274, 609-613.
5. 2. J. Neurosci. 23, 2744-2750.
6. Baik J. H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M. and Borrelli E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
7. Batchelor M. and Schenk J. O. (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 10304-10309.
8. Benoit-Marand M., Jaber M. and Gonon F. (2000) Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur. J. Neurosci. 12, 2985-2992.
9. Benoit-Marand M., Borrelli E. and Gonon F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134-9141.
10. Bernard V. and Bolam J. P. (1998) Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor. Eur. J. Neurosci. 10, 3721-3736.
11. Blakely R. D. and Bauman A. L. (2000) Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10, 328-336.
12. Broderick P. A. and Piercey M. F. (1998) Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. J. Neural Transm. 105, 749-767.
13. Brown J. M., Hanson G. R. and Fleckenstein A. E. (2001) Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. J. Pharmacol. Exp. Ther 298, 1150-1153.
14. Brown J. M., Riddle E. L., Sandoval V., Weston R. K., Hanson J. E., Crosby M. J., Ugarte Y. V., Gibb J. W., Hanson G. R. and Fleckenstein A. E. (2002) A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol. Exp. Ther. 302, 497-501.
15. Budygin E. A., John C. E., Mateo Y. and Jones S. R. (2002) Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J. Neurosci. 22, RC222.
16. Bunney B. S. and Grace A. A. (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci. 23, 1715-1727.
17. Bunney B. S., Walters J. R., Roth R. H. and Aghajanian G. K. (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185, 560-571.
18. Burn J. H. and Rand M. J. (1958) The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. 144, 314-336.
19. Cabin D. E., Shimazu K., Murphy D., Cole N. B., Gottschalk W., McIlwain K. L., Orrison B., Chen A., Ellis C. E., Paylor R. et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
20. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 7, 87-106.
21. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B. and Di Chiara G. (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J. Neurosci. 21, RC141: 141-144.
22. Cardozo D. L. and Bean B. P. (1995) Voltage-dependent calcium channels in rat midbrain dopamine neurons modulation by dopamine and GABAB receptors. J Neurophysiol. 74, 1137-1148.
23. Carlsson A. (1975) Dopaminergic autoreceptors, in: Chemical Tools in Catecholamine Research, Vol. II (Almgren O., Carlsson A. and Engel J., eds), pp. 219-225. North-Holland Publishing Co, Amsterdam.
24. Cass W. A. and Gerhardt G. A. (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176, 259-263.
25. Cass W. A., Gerhardt G. A., Mayfield R. D., Curella P. and Zahniser N. R. (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59, 259-266.
26. Cathala L. and Paupardin-Tritsch D. (1999) Effect of catecholamines on the hyperpolarization-activated cationic Ih and the inwardly rectifying potassium I (Kir) currents in the rat substantia nigra pars compacta. Eur. J. Neurosci. 11, 398-406.
27. Centonze D., Usiello A., Gubellini P., Pisani A., Borrelli E., Bernardi G. and Calabresi P. (2002) Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology 27, 723-726.
28. Charara A., Heilman C., Levey A. I. and Smith Y. (2000) Pre- and postsynaptic localization of GABAB receptors in the basal ganglia in monkeys. Neuroscience 95, 127-140.
29. Chen N. and Justice J. B. Jr (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport. J. Neurosci. 18, 10257-10268.
30. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21, 7841-7847.
31. Chen Q., Veenman L., Knopp K., Yan Z., Medina L., Song W. J., Surmeier D. J. and Reiner A. (1998) Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience 83, 749-761.
32. Chergui K., Suaud-Chagny M. F. and Gonon F. (1994) Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62, 641-645.
33. Chergui K., Nomikos G. G., Mathe J. M., Gonon F. and Svensson T. H. (1996) Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat. Neuroscience 72, 141-156.
34. Chergui K., Svenningsson P., Nomikos G. G., Gonon F., Fredholm B. B. and Svennson T. H. (1997) Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle. Eur. J. Neurosci. 9, 2370-2382.
35. Chiodo L. A., Bannon M. J., Grace A. A., Roth R. H. and Bunney B. S. (1984) Evidence for the absence of impulse-regulating somato-dendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12, 1-16.
36. Colliver T. L., Pyott S. J., Achalabun M. and Ewing A. G. (2000) VMAT-mediated changes in quantal size and vesicular volume. J. Neuroscience 20, 5276-5282.
37. Congar P., Bergevin A. and Trudeau L. E. (2002) D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K(+) channels. J. Neurophysiol. 87, 1046-1056.
38. Copeland B. J., Vogelsberg V., Neff N. H. and Hadjiconstantinou M. (1996) Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 277, 1527-1532.
39. Cragg S. J. and Greenfield S. A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17, 5738-5746.
40. Cragg S. J., Hille C. J. and Greenfield S. A. (2000) Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. J. Neurosci. 20, 8209-8217.
41. Cragg S. J., Nicholson C., Kume-Kick J., Tao L. and Rice M. E. (2001) Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J. Neurophysiol. 85, 1761-1771.
42. Cragg S. J., Hille C. J. and Greenfield S. A. (2002) Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J. Neurosci. 22, 5705-5712.
43. Cubeddu L. X. and Hoffmann I. S. (1982) Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors. J. Pharmacol. Exp. Ther. 223, 497-501.
44. Daniels G. M. and Amara S. G. (1999) Regulated trafficking of the human dopamine transporter: clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794-35801.
45. Davidson C., Ellinwood E. H. and Lee T. H. (2000) Altered sensitivity of dopamine autoreceptors in rat accumbens 1 and 7 days after intermittent or continuous cocaine withdrawal. Brain Res. Bull. 51, 89-93.
46. Davila V., Yan Z., Cracium L. C., Logothetis D. and Sulzer D. (2003) D3 dopamine autoreceptors do not activate GIRK channel currents in substantia nigra dopamine neurons. J. Neurosci. 23, 5693-5697.
47. Daws L. C., Callaghan P. D., Moron J. A., Kahlig K. M., Shippenberg T. S., Javitch J. A. and Galli A. (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Biophys. Res. Commun. 290, 1545-1550.
48. Dean B. and Hussain T (2001) Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia. Schizophr Res. 52, 107-114.
49. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J. C. and Sokoloff P. (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J. Neurosci. 20, 8677-8684.
50. Dickinson S. D., Sabeti J., Larson G. A., Giardina K., Rubinstein M., Kelly M. A., Grandy D. K., Low M. J., Gerhardt G. A. and Zahniser N. R. (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148-156.
51. Dugast C., Brun P., Sotty F., Renaud B. and Suaud-Chagny M. F. (1997) On the involvement of a tonic dopamine D2-autoinhibition in the regulation of pulse-to-pulse-evoked dopamine release in the rat striatum in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 355, 716-719.
52. Dwoskin L. P. and Zahniser N. R. (1986) Robust modulation of [3H] dopamine release from rat striatal slices by D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 239, 442-453.
53. Earles C. and Schenk J. O. (1998) Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation. Anal. Biochem. 264, 191-198.
54. Ewing A. G., Bigelow J. C. and Wightman R. M. (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221, 169-171.
55. Falkenburger B. H., Barstow K. L. and Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 2465-2470.
56. Fischer J. F. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203-209.
57. Freeman A. S. and Bunney B. S. (1987) Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res. 405, 46-55.
58. Gainetdinov R. R., Sotnikova T. D., Grekhova T. V. and Rayevsky K. S. (1996) In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur. J. Pharmacol. 308, 261-269.
59. Gainetdinov R. R., Jones S. R., Fumagalli F., Wightman R. M. and Caron M. G. (1998) Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res. Brain Res. Rev. 26, 148-153.
60. Gainetdinov R. R., Wetsel W. C., Jones S. R., Levin E. D., Jaber M. and Caron M. G. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401.
61. Galloway M. P., Wolf M. E. and Roth R. H. (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J. Pharmacol. Exp. Ther 236, 689-698.
62. Garris P. A. and Wightman R. M. (1994) Different kinetics govem dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442-450.
63. Garris P. A., Ciolkowski E. L., Pastore P. and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
64. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F. et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
65. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
66. Gonon F. G. (1986) Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry. Ann. N Y Acad. Sci. 473, 160-169.
67. Gonon F. G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24, 19-28.
68. Gonon F. (1997) Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J. Neurosci. 17, 5972-5978.
69. Gonon F. G. and Buda M. J. (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14, 765-774.
70. Gonon F., Buda M., Cespuglio R., Jouvet M. and Pujol J. F. (1980) In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? Nature 286, 902-904.
71. Gonon F., Burie J. B., Jaber M., Benoit-Marand M., Dumartin B. and Bloch B. (2000) Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter. Prog. Brain Res. 125, 291-302.
72. Grace A. A. and Bunney B. S. (1984a) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877-2890.
73. Grace A. A. and Bunney B. S. (1984b) The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4, 2866-2876.
74. Grace A. A., Bunney B. S., Moore H. and Todd C. L. (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20, 31-37.
75. Granas C., Ferrer J., Loland C. J., Javitch J. A. and Gether U. (2003) N-Terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 4990-5000.
76. Grondin R., Cass W. A., Zhang Z., Stanford J. A., Gash D. M. and Gerhardt G. A. (2003) Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J. Neurosci. 23, 1974-1980.
77. Gulley J. M., Doolen S. and Zahniser N. R. (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J. Neurochem. 83, 400-411.
78. Haubrich D. R. and Pflueger A. B. (1982) The autoreceptor control of dopamine synthesis: an in vitro and in vivo comparison of dopamine agonists. Mol. Pharmacol. 21, 114-120.
79. Hebert M. A., Van Horne C. G., Hoffer B. J. and Gerhardt G. A. (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther. 279, 1181-1190.
80. 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J. Pharmacol. Exp. Ther 194, 47-56.
81. Henry D. J., Hu X. T. and White F. J. (1998) Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology (Berl.) 140, 233-242.
82. Henry D. J., Greene M. A. and White F. J. (1989) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmacol. Exp. Ther 251, 833-839.
83. Hoffman A. F., Zahniser N. R., Lupica C. R. and Gerhardt G. A. (1999) Voltage-dependency of the dopamine transporter in the rat substantia nigra. Neurosci. Lett. 260, 105-108.
84. Horn A. S. (1979) Characteristics of dopamine uptake, in: The Neurobiology of Dopamine (Westerink, B. H. C., ed.), pp. 217-235. Academic Press, London.
85. Horn A. S. (1990) Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34, 387-400.
86. Howard S. G., Fisher R. and Landry C. F. (1997) Alterations in the spontaneous release of dopamine and the density of the DA D2 receptor mRNA after chronic postnatal exposure to cocaine. Brain Res. Bull. 43, 101-106.
87. max. J. Neurochem. 68, 225-232.
88. Huff R. M., Chio C. L., Lajiness M. E. and Goodman L. V. (1998) Signal transduction pathways modulated by D2-like dopamine receptors. Adv. Pharmacol. 42, 454-457.
89. Iannazzo L., Sathananthan S. and Majewski H. (1997) Modulation of dopamine release from rat striatum by protein kinase C: interaction with presynaptic D2-dopamine-autoreceptors. Br. J. Pharmacol. 122, 1561-1566.
90. Ingram S. L., Prasad B. M. and Amara S. G. (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5, 971-978.
91. Iravani M. M. and Kruk Z. L. (1995) Effects of amphetamine on carrier-mediated and electrically stimulated dopamine release in slices of rat caudate putamen and nucleus accumbens. J. Neurochem. 64, 1161-1168.
92. Jaffe E. H., Marty A., Schulte A. and Chow R. H. (1998) Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. J. Neurosci. 18, 3548-3553.
93. Jahr C. E. (2003) Drooling and stuttering, or do synapses whisper? Trends Neurosci. 26, 7-9.
94. Jones S. R., Garris P. A. and Wightman R. M. (1995a) Different effects of cocaine and nomifensine on dopamine uptake in the caudateputamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396-403.
95. Jones S. R., Garris P. A., Kilts C. D. and Wightman R. M. (1995b) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J. Neurochem. 64, 2581-2589.
96. Jones S. R., Lee T. H., Wightman R. M. and Ellinwood E. H. (1996a) Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl.) 126, 331-338.
97. Jones S. R., O'Dell S. J., Marshall J. F. and Wightman R. M. (1996b) Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain. Synapse 23, 224-231.
98. Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998a) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
99. Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. and Caron M. G. (1998b) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95, 4029-4034.
100. Jones S. R., Joseph J. D., Barak L. S., Caron M. G. and Wightman R. M. (1999a) Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73, 2406-2414.
101. Jones S. R., Gainetdinov R. R., Hu X. T., Cooper D. C., Wightman R. M., White F. J. and Caron M. G. (1999b) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2, 649-655.
102. Joseph J. D., Wang Y. M., Miles P. R., Budygin E. A., Picetti R., Gainetdinov R. R., Caron M. G. and Wightman R. M. (2002) Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112, 39-49.
103. Jung M. Y., Skryabin B. V., Arai M., Abbondanzo S., Fu D., Brosius J., Robakis N. K., Polites H. G., Pintar J. E. and Schmauss C. (1999) Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience 91, 911-924.
104. Kalivas P. W. and Duffy P. (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56, 961-967.
105. Kalsner S. (2001) Autoreceptors do not regulate routinely neurotransmitter release: focus on adrenergic systems. J. Neurochem. 78, 676-684.
106. Kapatos G. and Zigmond M. J. (1979) Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes. J. Pharmacol. Exp. Ther. 208, 468-475.
107. Kawagoe K. T., Garris P. A., Wiedemann D. J. and Wightman R. M. (1992) Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience 51, 55-64.
108. Kawagoe K. T., Zimmerman J. B. and Wightman R. M. (1993) Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods 48, 225-240.
109. Kehr W., Carlsson A., Lindqvist M., Magnusson T. and Atack C. (1972) Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744-747.
110. Kennedy R. T., Jones S. R. and Wightman R. M. (1992) Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J. Neurochem. 59, 449-455.
111. Khan Z. U., Mrzljak L., Gutierrez A., de la Calle A. and Goldman-Rakic P. S. (1998) Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc. Natl. Acad. Sci. USA 95, 7731-7736.
112. +-dependent mechanism. J. Biol. Chem. 29, 29.
113. Kim K. M., Nakajima Y. and Nakajima S. (1995) G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons. Neuroscience 69, 1145-1158.
114. Kimmel H. L., Carroll F. I. and Kuhar M. J. (2003) Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J. Pharmacol. Exp. Ther 304, 15-21.
115. Kimmel H. L., Joyce A. R., Carroll F. I. and Kuhar M. J. (2001) Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J. Pharmacol. Exp. Ther 298, 129-140.
116. King G. R., Xiong Z., Douglas S., Lee T. H. and Ellinwood E. H. (1999) The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function. Eur. J. Pharmacol. 376, 207-215.
117. Kissinger P. T., Hart J. B. and Adams R. N. (1973) Voltammetry in brain tissue - a new neurophysiological measurement. Brain Res. 55, 209-213.
118. Kitai S. T., Shepard P. D., Callaway J. C. and Scroggs R. (1999) Afferent modulation of dopamine neuron firing patterns. Curr Opin. Neurobiol. 9, 690-697.
119. Koeltzow T. E., Xu M., Cooper D. C., Hu X. T., Tonegawa S., Wolf M. E. and White F. J. (1998) Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18, 2231-2238.
120. Kozminski K. D., Gutman D. A., Davila V., Sulzer D. and Ewing A. G. (1998) Voltammetric and pharmacological characterization of dopamine released from single quantal events in PC12 cells. Anal. Chem. 70, 3123-3130.
121. Kreiss D. S., Bergstrom D. A., Gonzalez A. M., Huang K. X., Sibley D. R. and Walters J. R. (1995) Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities. Eur. J. Pharmacol. 277, 209-214.
122. Krueger B. K. (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55, 260-267.
123. Kudernatsch M. and Sutor B. (1994) Cholinergic modulation of dopamine overflow in the rat neostriatum: a fast cyclic voltammetric study in vitro. Neurosci. Lett. 181, 107-112.
124. Kuhar M. J. and Pilotte N. S. (1996) Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 17, 260-264.
125. Kula N. S. and Baldessarini R. J. (1991) Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 30, 89-92.
126. Kulagina N. V., Zigmond M. J. and Michael A. C. (2001) Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 102, 121-128.
127. Kullmann D. M. and Asztely F. (1998) Extrasynaptic glutamate spillover in the hippocampus: evidence and implications. Trends Neurosci. 21, 8-14.
128. Kuzhikandathil E. V. and Oxford G. S. (1999) Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. J. Neurosci. 19, 1698-1707.
129. Kuzhikandathil E. V. and Oxford G. S. (2000) Dominant-negative mutants identify a role for GIRK channels in D3 dopamine receptor-mediated regulation of spontaneous secretory activity. J. Gen. Physiol. 115, 697-706.
130. Kuzhikandathil E. V., Yu W. and Oxford G. S. (1998) Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines. Mol. Cell Neurosci. 12, 390-402.
131. L'hirondel M., Cheramy A., Godeheu G., Artaud F., Saiardi A., Borrelli E. and Glowinski J. (1998) Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res. 792, 253-262.
132. Laakso A., Bergman J., Haaparanta M., Vilkman H., Solin O., Syvalahti E. and Hietala J. (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr. Res. 52, 115-120.
133. Lacey M. G., Mercuri N. B. and North R. A. (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol. 392, 397-416.
134. Lee T. H., Gao W. Y. and Ellinwood E. H. (1997) Differential effects of SCH 23390 on the apomorphine subsensitivity in the substantia nigra and ventral tegmental area 1 day following withdrawal from continuous or intermittent cocaine pretreatment. Brain Res. 744, 293-301.
135. Lejeune F. and Millan M. J. (1995) Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur. J. Pharmacol. 275, R7-R9.
136. Limberger N., Trout S. J., Kruk Z. L. and Starke K. (1991) 'Real time' measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623-629.
137. Lindgren N., Xu Z. Q., Herrera-Marschitz M., Haycock J., Hokfelt T. and Fisone G. (2001) Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur. J. Neurosci. 13, 773-780.
138. Little K. Y., Elmer L. W., Zhong H., Scheys J. O. and Zhang L. (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61, 436-445.
139. Lu W. and Wolf M. E. (1997) Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Brain Res. Mol. Brain Res. 49, 137-148.
140. Marsden C. A., Joseph M. H., Kruk Z. L., Maidment N. T., O'Neill R. D., Schenk J. O. and Stamford J. A. (1988) In vivo voltammetry - present electrodes and methods. Neuroscience 25, 389-400.
141. Matsumoto M., Weickert C. S., Akil M., Lipska B. K., Hyde T. M., Herman M. M., Kleinman J. E. and Weinberger D. R. (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116, 127-137.
142. May L. J. and Wightman R. M. (1989) Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen. J. Neurochem. 53, 898-906.
143. Mayer A., Limberger N. and Starke K. (1988) Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors. Naunyn Schmiedebergs Arch. Pharmacol. 338, 632-643.
144. Mayfield R. D. and Zahniser N. R. (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol. Pharmacol. 59, 113-121.
145. McElvain J. S. and Schenk J. O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189-2199.
146. McGehee D. S., Heath M. J., Gelber S., Devay P. and Role L. W. (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
147. Meiergerd S. M., Patterson T A. and Schenk J. O. (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
148. Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699-7710.
149. Melis M., Mereu G., Lilliu V., Quartu M., Diana M. and Gessa G. L. (1998) Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats. Brain Res. 783, 127-132.
150. Mercuri N. B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G. and Borrelli E. (1997) Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 79, 323-327.
151. el Mestikawy S. and Hamon M. (1986) Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals? J. Neurochem. 47, 1425-1433.
152. Michael D. J. and Wightman R. M. (1999) Electrochemical monitoring of biogenic amine neurotransmission in real time. J. Pharm. Biomed. Anal. 19, 33-46.
153. Millar J., Stamford J. A., Kruk Z. L. and Wightman R. M. (1985) Electrochemical, pharmacological and electrophysiological evidence of rapid dopamine release and removal in the rat caudate nucleus following electrical stimulation of the median forebrain bundle. Eur. J. Pharmacol. 109, 341-348.
154. Miner L. H., Schroeter S., Blakely R. D. and Sesack S. R. (2000) Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J. Comp. Neurol. 427, 220-234.
155. Mintz M., Gordon I., Roz N. and Rehavi M. (1994) The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats. Brain Res. 668, 239-242.
156. Moron J. A., Brockington A., Wise R. A., Rocha B. A. and Hope B. T (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389-395.
157. Mosharov E., Gong L., Khanna B., Sulzer D. and Lindau M. (2003) Intracellular patch electrochemistry: cytosolic catecholamines in chromaffin cells. J. Neurosci. 23, 5835-5845.
158. Mundorf M. L., Joseph J. D., Austin C. M., Caron M. G. and Wightman R. M. (2001) Catecholamine release and uptake in the mouse prefrontal cortex. J. Neurochem. 79, 130-142.
159. Murphy D. D., Rueter S. M., Trojanowski J. Q. and Lee V. M. (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220.
160. Murthy V. N., Schikorski T., Stevens C. F. and Zhu Y. (2001) Inactivity produces increases in neurotransmitter release and synapse size. Neuron 32, 673-682.
161. Near J. A., Bigelow J. C. and Wightman R. M. (1988) Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Ther. 245, 921-927.
162. Nicholson C. (1995) Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. Biophys. J. 68, 1699-1715.
163. Nicholson C. (2000) Volume transmission in the year 2000. Prog. Brain Res. 125, 437-446.
164. Nirenberg M. J., Vaughan R. A., Uhl G. R., Kuhar M. J. and Pickel V. M. (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16, 436-447.
165. Nirenberg M. J., Chan J., Pohorille A., Vaughan R. A., Uhl G. R., Kuhar M. J. and Pickel V. M. (1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J. Neurosci. 17, 6899-6907.
166. O'Hara C. M., Uhland-Smith A., O'Malley K. L. and Todd R. D. (1996) Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J. Pharmacol. Exp. Ther. 277, 186-192.
167. Onali P. and Olianas M. C. (1989) Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens. Neurosci. Lett. 102, 91-96.
168. Paladini C. A., Robinson S., Morikawa H., Williams J. T. and Palmiter R. D. (2003) Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism. Proc. Natl. Acad. Sci. USA 100, 2866-2871.
169. Palij P., Bull. D. R., Sheehan M. J., Millar J., Stamford J., Kruk Z. L. and Humphrey P. P. (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res. 509, 172-174.
170. Parish C. L., Finkelstein D. I., Drago J., Borrelli E. and Horne M. K. (2001) The role of dopamine receptors in regulating the size of axonal arbors. J. Neurosci. 21, 5147-5157.
171. Parker E. M. and Cubeddu L. X. (1986) Effects of D-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237, 179-192.
172. Parsons L. H., Schad C. A. and Justice J. B. Jr (1993) Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60, 376-379.
173. Persico A. M., Schindler C. W., Brannock M. T., Gonzalez A. M., Surratt C. K. and Uhl G. R. (1993) Dopaminergic gene expression during amphetamine withdrawal. Neuroreport 4, 41-44.
174. Phillips P. E. and Stamford J. A. (2000) Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res. 884, 139-146.
175. Phillips P. E., Hancock P. J. and Stamford J. A. (2002) Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44, 15-22.
176. Pickel V. M., Chan J. and Nirenberg M. J. (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45, 113-124.
177. Pothos E., Desmond M. and Sulzer D. (1996) L-3,4-Dihydroxyphenylalanine increases the quantal size of exocytic dopamine release in vitro. J. Neurochem. 66, 629-636.
178. Pothos E., Davila V. and Sulzer D. (1998a) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18, 4106-4118.
179. Pothos E. N., Przedborski S., Davila V., Schmitz Y. and Sulzer D. (1998b) D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J. Neurosci. 18, 5575-5585.
180. Pothos E. N., Larsen K. E., Krantz D. E., Liu Y.-J., Edwards R. H. and Sulzer D. (2000) Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J. Neurosci. 20, 7297-7306.
181. Povlock S. L. and Schenk J. O. (1997) A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine. J. Neurochem. 69, 1093-1105.
182. Prasad B. M. and Amara S. G. (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J. Neurosci. 21, 7561-7567.
183. Pristupa Z. B., McConkey F., Liu F., Man H. Y., Lee F. J., Wang Y. T. and Niznik H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30, 79-87.
184. Puopolo M., Hochstetler S. E., Gustincich S., Wightman R. M. and Raviola E. (2001) Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation. Neuron 30, 211-225.
185. Raiteri M., Cerrito F., Cervoni A. M. and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195-202.
186. Rayport S., Sulzer D., Shi W. X., Sawasdikosol S., Monaco J., Batson D. and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology. J. Neurosci. 12, 4264-4280.
187. 3H)cocaine binding in central nervous system of mouse. Life Sci. 27, 1055-1062.
188. Rice M. E. (2000) Distinct regional differences in dopamine-mediated volume transmission. Prog. Brain Res. 125, 277-290.
189. Rice M. E., Gerhardt G. A., Hierl P. M., Nagy G. and Adams R. N. (1985) Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience 15, 891-902.
190. Rice M. E., Cragg S. J. and Greenfield S. A. (1997) Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J. Neurophysiol. 77, 853-862.
191. Ritz M. C., Lamb R. J., Goldberg S. R. and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
192. Rivet J. M., Audinot V., Gobert A., Peglion J. L. and Millan M. J. (1994) Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Eur. J. Pharmacol. 265, 175-177.
193. Rocha B. A., Fumagalli F., Gainetdinov R. R., Jones S. R., Ator R., Giros B., Miller G. W. and Caron M. G. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1, 132-137.
194. Rosenblad C., Martinez-Serrano A. and Bjorklund A. (1998) Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82, 129-137.
195. Ross S. B. (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J. Neurochem. 56, 22-29.
196. Roth R. H., Walters J. R., Murrin L. C., Morgenroth V. H. and 3rd (1975) Dopamine neurons: role of impulse flow and presynaptic receptors in the regulation of tyrosine hydroxylase. Psychopharmacol. Bull. 11, 8.
197. Rothblat D. S. and Schneider J. S. (1997) Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci. Lett. 228, 119-122.
198. Rouge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P. V. and Borrelli E. (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci. 22, 3293-3301.
199. Rubinstein M., Phillips T. J., Bunzow J. R., Falzone T. L., Dziewczapolski G., Zhang G., Fang Y., Larson J. L., McDougall J. A., Chester J. A. et al. (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90, 991-1001.
200. Sabeti J., Adams C. E., Burmeister J., Gerhardt G. A. and Zahniser N. R. (2002) Kinetic analysis of striatal clearance of exogenous dopamine recorded by chronoamperometry in freely-moving rats. J. Neurosci. Methods 121, 41-52.
201. Salah R. S., Kuhn D. M. and Galloway M. P. (1989) Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices. J. Neurochem. 52, 1517-1522.
202. Sandoval V., Riddle E. L., Ugarte Y. V., Hanson G. R. and Fleckenstein A. E. (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J. Neurosci. 21, 1413-1419.
203. Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M., Carvelli L., Javitch J. A. and Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl. Acad. Sci. USA 97, 6850-6855.
204. Schmitz Y., Schmauss C. and Sulzer D. (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J. Neurosci 22, 8002-8009.
205. Schmitz Y., Lee C. J., Schmauss C., Gonon F. and Sulzer D. (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J. Neurosci. 21, 5916-5924.
206. Schonfuss D., Reum T., Olshausen P., Fischer T. and Morgenstern R. (2001) Modelling constant potential amperometry for investigations of dopaminergic neurotransmission kinetics in vivo. J. Neurosci. Methods 112, 163-172.
207. Schultz W., Dayan P. and Montague P. R. (1997) A neural substrate of prediction and reward. Science 275, 1593-1599.
208. Seeman P. and Lee T (1975) Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188, 1217-1219.
209. Sesack S. R., Aoki C. and Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88-106.
210. Sesack S. R., Hawrylak V. A., Matus C., Guido M. A. and Levey A. I. (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18, 2697-2708.
211. Shilling P. D., Kelsoe J. R. and Segal D. S. (1997) Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci. Lett. 236, 131-134.
212. Silva N. L. and Bunney B. S. (1988) Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine. Eur. J. Pharmacol. 149, 307-315.
213. Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P. and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974.
214. Sora I., Wichems C., Takahashi N., Li X. F., Zeng Z., Revay R., Lesch K. P., Murphy D. L. and Uhl G. R. (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. USA 95, 7699-7704.
215. Sora I., Hall F. S., Andrews A. M., Itokawa M., Li X. F., Wei H. B., Wichems C., Lesch K. P., Murphy D. L. and Uhl G. R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl. Acad. Sci. USA 98, 5300-5305.
216. Stamford J. A., Kruk Z. L. and Millar J. (1988a) Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Br. J. Pharmacol. 94, 924-932.
217. Stamford J. A., Kruk Z. L., Palij P. and Millar J. (1988b) Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry. Brain Res. 448, 381-385.
218. Starke K. (2001) Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J. Neurochem. 78, 685-693.
219. Starke K., Reimann W., Zumstein A. and Hertting G. (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch. Pharmacol. 305, 27-36.
220. Strait K. A. and Kuczenski R. (1986) Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. Mol. Pharmacol. 29, 561-569.
221. Suaud-Chagny M. F., Ponec J. and Gonon F. (1991) Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry. Neuroscience 45, 641-652.
222. Suaud-Chagny M. F., Dugast C., Chergui K., Msghina M. and Gonon F. (1995) Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. J. Neurochem. 65, 2603-2611.
223. Sulzer D. and Pothos E. N. (2000) Presynaptic mechanisms that regulate quantal size. Rev. Neurosci. 11, 159-212.
224. Sulzer D. and Rayport S. (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797-808.
225. Sulzer D., Maidment N. T. and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
226. Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
227. Sulzer D., Joyce M. P., Lin L., Geldwert D., Haber S. N., Hattori T. and Rayport S. (1998) Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci. 18, 4588-4602.
228. Svingos A. L., Clarke C. L. and Pickel V. M. (1999) Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse 34, 1-10.
229. Svingos A. L., Periasamy S. and Pickel V. M. (2000) Presynaptic dopamine D(4) receptor localization in the rat nucleus accumbens shell. Synapse 36, 222-232.
230. Svingos A. L., Chavkin C., Colago E. E. and Pickel V. M. (2001) Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42, 185-192.
231. Tang L., Todd R. D. and O'Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475-479.
232. Tepper J. M., Sun B. C., Martin L. P. and Creese I. (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci. 17, 2519-2530.
233. Torres G. E., Gainetdinov R. R. and Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 13-25.
234. Uhl G. R., Hall F. S. and Sora I. (2002) Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7, 21-26.
235. Usiello A., Baik J. H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P. V. and Borrelli E. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199-203.
236. Vander Borght T., Kilbourn M., Desmond T., Kuhl D. and Frey K. (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur. J. Pharmacol. 294, 577-583.
237. Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 15541-15546.
238. Vizi E. S. (1982) Non-synaptic intercellular communication: presynaptic inhibition. Acta Biol. 33, 331-351.
239. Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M. P. and Sankoorikal E. B. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20, 8305-8314.
240. Wayment H. K., Schenk J. O. and Sorg B. A. (2001) Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J. Neurosci. 21, 35-44.
241. Wheeler D. D., Edwards A. M., Chapman B. M. and Ondo J. G. (1994) Effects of cocaine on sodium dependent dopamine uptake in rat striatal synaptosomes. Neurochem. Res. 19, 49-56.
242. White F. J. and Kalivas P. W. (1998) Neuroadaptations involved in amphetamine and cocaine addiction, Drug Alcohol Depend. 51, 141-153.
243. Wieczorek W. J. and Kruk Z. L. (1994a) A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice. Brain Res. 657, 42-50.
244. Wieczorek W. J. and Kruk Z. L. (1994b) Differential action of (+)-amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens. Br. J. Pharmacol. 111, 829-836.
245. Wightman R. M. and Zimmerman J. B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15, 135-144.
246. Wightman R. M., Amatore C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G. and May L. J. (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513-523.
247. Wolf M. E. and Roth R. H. (1990) Autoreceptor regulation of dopamine synthesis. Ann. N Y Acad. Sci. 604, 323-343.
248. Wolf M. E., Galloway M. P. and Roth R. H. (1986) Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. J. Pharmacol. Exp. Ther. 236, 699-707.
249. Wonnacott S., Kaiser S., Mogg A., Soliakov L. and Jones I. W. (2000) Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393, 51-58.
250. Wu X. and Gu H. H. (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233, 163-170.
251. Wu Y., Pearl S. M., Zigmond M. J. and Michael A. C. (2000) Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience 96, 65-72.
252. Wu Q., Reith M. E., Kuhar M. J., Carroll F. I. and Garris P. A. (2001a) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J. Neurosci. 21, 6338-6347.
253. Wu Q., Reith M. E., Wightman R. M., Kawagoe K. T. and Garris P. A. (2001b) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119-133.
254. Wu Q., Reith M. E., Walker Q. D., Kuhn C. M., Carroll F. I. and Garris P. A. (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J. Neurosci. 22, 6272-6281.
255. Yamamoto B. K. and Novotney S. (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71, 274-280.
256. 3H-DA release by D2 autoreceptors. Pharmacol. Biochem. Behav. 36, 457-461.
257. Yung K. K., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J. and Levey A. I. (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65, 709-730.
258. Zachariou V., Benoit-Marand M., Allen P. B., Ingrassia P., Fienberg A. A., Gonon F., Greengard P. and Picciotto M. R. (2002) Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biol. Psychiatry 51, 612-620.
259. Zahniser N. R. and Doolen S. (2001) Chronic and acute regulation of Na(+)/Cl(-)-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21-55.
260. Zhang L., Coffey L. L. and Reith M. E. (1997) Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53, 677-688.
261. Zhang H. and Sulzer D. (2003) Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J. Neurosci. (in press).
262. Zhou F. M., Liang Y. and Dani J. A. (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4, 1224-1229.
263. Zhu S. J., Kavanaugh M. P., Sonders M. S., Amara S. G. and Zahniser N. R. (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282, 1358-1365.
264. Zoli M., Jansson A., Sykova E., Agnati L. F. and Fuxe K. (1999) Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20, 142-150.